42451-07-0

Basic information

• Product Name: 2-methyl-6-ethyl-3-hydroxypyridine
• Synonyms: 2-methyl-6-ethyl-3-hydroxypyridine;6-Ethyl-3-hydroxy-2-Methylpyridine
• CAS NO: 42451-07-0
• Molecular Formula: C8H11NO
• Molecular Weight: 137.18
• Mol File: 42451-07-0.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 290.5°C at 760 mmHg
• Flash Point: 129.5°C
• Appearance: /
• Density: 1.053g/cm³
• Vapor Pressure: 0.00118mmHg at 25°C
• Refractive Index: 1.536
• CAS DataBase Reference: 2-methyl-6-ethyl-3-hydroxypyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-methyl-6-ethyl-3-hydroxypyridine(42451-07-0)
• EPA Substance Registry System: 2-methyl-6-ethyl-3-hydroxypyridine(42451-07-0)

Safety Data

• Hazardous Substances Data: 42451-07-0(Hazardous Substances Data)

Usage

InChI:InChI=1/C8H11NO/c1-3-7-4-5-8(10)6(2)9-7/h4-5,10H,3H2,1-2H3

Upstream product

• 133712-88-6 1-(5-Ethyl-furan-2-yl)-ethylamine 
• 126325-47-1 3-amino-6-bromo-2-methylpyridine 
• 1121-25-1 2-methyl-3-pyridinol 
• 848952-39-6 6-iodo-2-methylpyridin-3-ol 
• 136673-03-5 1-(5-Ethyl-furan-2-yl)-ethanone oxime 
• 24119-98-0 2-acetyl-5-ethylfuran 
• 3208-16-0 2-ethylfuran 

Relevant articles and documents

(PYRIDIN-2-YL)AMINE DERIVATIVES AS TGF-BETA R1 (ALK5) INHIBITORS FOR THE TREATMENT OF CANCER

The present invention relates to pharmaceutical compounds, compositions and methods, especially as they are related to compositions and methods for the treatment and/or prevention of a proliferation disorder associated with ΤGFβR1 activity, such as a cancer or fibrosis. The invention provides compounds of Formula (I) and Formula (II) as further described herein having an acidic moiety that enhances tissue specificity for targeted tissues and organs. The invention includes pharmaceutical compositions, pharmaceutical combinations, and methods of use of these compounds for treating conditions including cancer or fibrosis.